Edwyn

Edwyn Search companies, tickers, CIKs…⌘K

Encompass Health Corp

EHCCIK 0000785161

Compare:HCA UHS CYH SEM

Compare EHC

Intrinsic Value

EHC Intrinsic Valuation

Review the filing-backed discounted cash flow baseline, scenario range, and capital structure context for a fundamentals-first fair value read.

Intrinsic Value

EHC Intrinsic Valuation

Review the filing-backed discounted cash flow baseline, scenario range, and capital structure context for a fundamentals-first fair value read.

Intrinsic value

Filing-backed DCF baseline

Automated free-cash-flow DCF baseline for Encompass Health Corp, derived from annual filing data.

Read the DCF guide

DCF fair value

$27.33

Implied equity value $3B

Current price

—

Latest available quote for the primary listing.

Margin of safety

N/A

Live market price unavailable. Refreshing the route will retry the quote.

Fair value range

$19.69 – $37.28

Bear

$19.69

Base

$27.33

Bull

$37.28

Model assumptions

Cash flow base

$345M

Basis

Operating cash flow less capex (firm-value proxy)

Growth

10.0%

Discount

10.5%

Terminal

2.5%

Horizon

Assumption sensitivity

vs base per share

Base case$27.33Baseline

Growth +1 pt$37.60+$10.27

Intrinsic value

Filing-backed DCF baseline

Automated free-cash-flow DCF baseline for Encompass Health Corp, derived from annual filing data.

Read the DCF guide

DCF fair value

$27.33

Implied equity value $3B

Current price

—

Latest available quote for the primary listing.

Margin of safety

N/A

Live market price unavailable. Refreshing the route will retry the quote.

Fair value range

$19.69 – $37.28

Bear

$19.69

Base

$27.33

Bull

$37.28

Model assumptions

Cash flow base

$345M

Basis

Operating cash flow less capex (firm-value proxy)

Growth

10.0%

Discount

10.5%

Terminal

2.5%

Horizon

Assumption sensitivity

vs base per share

Base case$27.33Baseline

Growth +1 pt$37.60+$10.27

What the market is pricing in

Market expectations cannot be backed out until price, share count, cash-flow base, discount rate, terminal growth, and the EV-to-equity bridge are all available.
Growth anchor: Median of 3Y revenue CAGR, 5Y revenue CAGR, and 5Y free cash flow CAGR. Scenario-derived from +/-2 pts growth and +/-1 pt discount.
Net debt reduces equity value relative to firm value before the per-share target is calculated.

Intrinsic EV-to-equity bridge

Enterprise value

Discounted free cash flows

$5B

Less total debt

− $2B

Plus cash and equivalents

+ $72M

Equity value

After the bridge

$3B

Diluted shares

102,200,000

Fair value / share

$27.33